WeVote

Bill

Bill

HB 3317

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

89th Legislature (2025) Introduced by Cole Hefner and 1 co-sponsor

HB 3317 regulates pharmacy-PBM-insurer relationships, likely strengthening pharmacies' contractual protections and negotiating power against health benefit managers in Texas.

Laid on the table subject to call
0
WeVote Research Nonpartisan
Bill Summary · HB 3317

Legislative bill overview

HB 3317 addresses the contractual and operational relationships between pharmacists/pharmacies and health insurance entities (health benefit plan issuers and pharmacy benefit managers). The bill appears designed to regulate how these parties interact, negotiate, and potentially dispute terms—though specific provisions aren't detailed in the action history provided.

Why is this important

Pharmacy benefit managers (PBMs) and health insurers significantly control drug pricing, reimbursement rates, and patient access to medications. How pharmacies can contract with and challenge these entities directly affects medication affordability, pharmacy viability, and healthcare costs for consumers. Texas has seen increasing legislative focus on PBM practices due to complaints from independent pharmacies about unfair reimbursement rates.

Potential points of contention

  • PBM authority vs. pharmacy independence: Whether pharmacies gain stronger negotiating power or contractual protections against unilateral PBM/insurer actions
  • Reimbursement rate floors: If the bill mandates minimum reimbursement levels, insurers may argue this increases costs; pharmacies argue current rates are unsustainable
  • Dispute resolution mechanisms: Whether new grievance procedures favor one party over another or create bureaucratic burdens

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.